Charles River Laboratories International Inc
XBER:RV6
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Charles River Laboratories International Inc
XBER:RV6
|
US |
|
Fidelis Insurance Holdings Ltd
F:U0K
|
BM |
|
H
|
Hanjaya Mandala Sampoerna Tbk PT
SWB:HSZ
|
ID |
|
Kilroy Realty Corp
NYSE:KRC
|
US |
|
TUI AG
OTC:TUIFF
|
DE |
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
UK |
|
Liberty Oilfield Services Inc
NYSE:LBRT
|
US |
|
Surya Semesta Internusa Tbk PT
IDX:SSIA
|
ID |
|
Evli Oyj
F:V6O
|
FI |
|
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
JP |
|
Amazon.com Inc
MIL:1AMZN
|
US |
|
H
|
High Quality Food SpA
MIL:HQF
|
IT |
Wall St Price Targets
RV6 Price Targets Summary
Charles River Laboratories International Inc
According to Wall Street analysts, the average 1-year price target for RV6 is 168.52 EUR with a low forecast of 110.15 EUR and a high forecast of 212.02 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RV6's stock price target?
Price Target
168.52
EUR
According to Wall Street analysts, the average 1-year price target for RV6 is 168.52 EUR with a low forecast of 110.15 EUR and a high forecast of 212.02 EUR.
What is the Revenue forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Gross Profit forecast for Charles River Laboratories International Inc?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 8 years is 4%.
What is the Operating Income forecast for Charles River Laboratories International Inc?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 5 years is 15%.
